GB2152046B - 2-arylbenzothiazoline derivatives - Google Patents

2-arylbenzothiazoline derivatives

Info

Publication number
GB2152046B
GB2152046B GB08432034A GB8432034A GB2152046B GB 2152046 B GB2152046 B GB 2152046B GB 08432034 A GB08432034 A GB 08432034A GB 8432034 A GB8432034 A GB 8432034A GB 2152046 B GB2152046 B GB 2152046B
Authority
GB
United Kingdom
Prior art keywords
arylbenzothiazoline
derivatives
arylbenzothiazoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08432034A
Other languages
English (en)
Other versions
GB8432034D0 (en
GB2152046A (en
Inventor
Jun-Ichi Iwao
Tadashi Iso
Masayuki Oya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of GB8432034D0 publication Critical patent/GB8432034D0/en
Publication of GB2152046A publication Critical patent/GB2152046A/en
Application granted granted Critical
Publication of GB2152046B publication Critical patent/GB2152046B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08432034A 1983-12-27 1984-12-19 2-arylbenzothiazoline derivatives Expired GB2152046B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58251934A JPS60139679A (ja) 1983-12-27 1983-12-27 ２−アリ−ルベンゾチアゾリン誘導体

Publications (3)

Publication Number Publication Date
GB8432034D0 GB8432034D0 (en) 1985-01-30
GB2152046A GB2152046A (en) 1985-07-31
GB2152046B true GB2152046B (en) 1987-06-03

Family

ID=17230142

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08432034A Expired GB2152046B (en) 1983-12-27 1984-12-19 2-arylbenzothiazoline derivatives

Country Status (8)

Country Link
US (1) US4547513A (enExample)
JP (1) JPS60139679A (enExample)
KR (1) KR910004432B1 (enExample)
DE (1) DE3446992A1 (enExample)
ES (1) ES8603850A1 (enExample)
FR (1) FR2557109B1 (enExample)
GB (1) GB2152046B (enExample)
IT (1) IT1179549B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62221679A (ja) * 1986-03-19 1987-09-29 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
JPH066581B2 (ja) * 1986-03-19 1994-01-26 参天製薬株式会社 フエノキシアルキルアミン側鎖を有するベンゾチアゾリン誘導体
US5229398A (en) * 1990-02-27 1993-07-20 Adir Et Compagnie Aminomethylpiperidine compounds
EP1496053B1 (en) 2002-03-29 2012-06-20 Santen Pharmaceutical Co., Ltd. Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
EP1642590A4 (en) * 2003-07-04 2009-05-13 Santen Pharmaceutical Co Ltd MEANS TO INHIBIT THE DEGRADATION OF THE PAIN LIMIT
US7642274B2 (en) 2003-07-04 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825016A (en) * 1956-11-02 1959-12-09 Crookes Lab Ltd Therapeutic derivatives of aryl-benzthiazoles
US3720683A (en) * 1970-09-02 1973-03-13 Squibb & Sons Inc 2-phenyl-3-acylbenzothiazolines and their oxides
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類

Also Published As

Publication number Publication date
GB8432034D0 (en) 1985-01-30
IT1179549B (it) 1987-09-16
ES539066A0 (es) 1986-01-01
IT8424269A0 (it) 1984-12-27
KR910004432B1 (ko) 1991-06-27
ES8603850A1 (es) 1986-01-01
KR850004491A (ko) 1985-07-15
US4547513A (en) 1985-10-15
IT8424269A1 (it) 1986-06-27
GB2152046A (en) 1985-07-31
JPH0545587B2 (enExample) 1993-07-09
DE3446992A1 (de) 1985-07-04
JPS60139679A (ja) 1985-07-24
FR2557109A1 (fr) 1985-06-28
FR2557109B1 (fr) 1987-09-04

Similar Documents

Publication Publication Date Title
GB8334499D0 (en) Derivatives
GB8405980D0 (en) N-pyridylpyrazole derivatives
EP0129513A3 (en) Oxamic-acid derivatives
EP0135177A3 (en) Benzocycloalkane derivatives
GB8416172D0 (en) Spirosuccinide derivatives
GB2145084B (en) Fredericamycin derivatives
GB8427363D0 (en) Oxabicycloheptane derivatives
GB8415032D0 (en) 3-phenyl-4-cyano-pyrrole derivatives
GB2144119B (en) Fluoromethylthiooxacephalosporin derivatives
DE3475621D1 (en) 2-dioxacycloalkylthiopenem derivatives
GR80634B (en) 2-azacycloalkylthiopenem derivatives
GR80371B (en) 3-indolecarboxamide derivatives
GB2146991B (en) Fluorenylalkylimidazole derivatives
EG16589A (en) 2-azacycloalkylthiopenem derivatives
GB8432034D0 (en) 2-arylbenzothiazoline derivatives
GB8408128D0 (en) Gonadoliberine derivatives
DE3460649D1 (en) Cyanotercyclohexane derivatives
AR243155A1 (es) Procedimiento para la preparacion de nuevas benzamidas n-aminoetil-sustituidas.
EP0143001A3 (en) Pyrimidoisoquinoline derivatives
GR80515B (en) Fluoralkylatedcarbapenem derivatives
GR80582B (en) Azolyl-tetrahydrofuran-2-yliden-methan derivatives
GR82491B (en) Iminomethyl - azolyl derivatives
GR80442B (en) Triazolylmethyl-pyridyloxymethyl-carbinol derivatives
EP0125695A3 (en) 2-bromo-1-tetralone derivatives
GB8420270D0 (en) Derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19961219